首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献，搜索用时 46 毫秒
1.
Comparative studies of the efficacy of parvaquone (Parvexon) and parvaquone-plus-frusemide (Fruvexon) Bimeda Chemicals, Ireland, were done on 60 naturally infected cases of East Coast fever (ECF; Theileria parva infection in cattle). Small-scale dairy farmers in the peri-urban of Dar Es Salaam city reported ECF-suspected cases from March to mid-October 2001 and were treated with the two drugs alternately, as were diagnosed positive for ECF. Four sub-groups of 15 cattle each (early stage, 15; advanced stage, 15) were treated with parvaquone and parvaquone-plus-frusemide. Twenty-eight out of 30 (93.3%) cattle treated with parvaquone-plus-frusemide were cured, so do 24 out of 30 (80.0%) cattle treated with parvaquone without frusemide. Early diagnosis and prompt management of pulmonary signs, which accounted for 30.0% of total ECF cases is advised in order to improve cure rates. Unlike parvaquone without frusemide (Parvexon), parvaquone-plus-frusemide (Fruvexon) proved useful in the management of pulmonary signs, hence, a drug of choice in the treatment of ECF cases that are accompanied by or are likely to manifest pulmonary signs.  相似文献   

2.
Two trials were conducted to compare the efficacy of parvaquone and buparvaquone for the treatment of naturally acquired East Coast fever (ECF, Theileria parva infection) which, if untreated, is almost invariably fatal in European breeds of cattle. In the first trial 28 naive cattle were exposed in a paddock infested with ticks carrying a virulent form of the disease. Twelve were treated with each drug when they developed clinical ECF. All 24 cattle were cured. In the second study, 100 cases of ECF occurring naturally on farms in Kenya were treated, 50 with each drug. Parvaquone cured 44 (88%) buparvaquone cured 45 (90%). Intercurrent infections, predominantly anaplasmosis and bacterial pneumonia or scour, were treated specifically. It is concluded that parvaquone and buparvaquone are similarly effective in curing ECF and cure rates are maximised by accurate diagnosis and prompt treatment of both ECF and intercurrent infections.  相似文献   

3.
Evaluation trials of the efficacy of buparvaquone (BUTA-kel KELA Laboratoria, N.V. Belgium), as a treatment of field cases of Theileria parva infection (East Coast fever - ECF) were carried out on 63 cattle in the peri-urban of Dar Es Salaam city, Tanzania, during the period November 2004 to August 2005. Thirty-two cattle (56%) received single-dose treatment (2.5 mg buparvaquone per kg body weight), while two and three-dose treatment with interval(s) of 48 h was given to 33% and 11% of total treated cattle, respectively; 38 cattle (60.3%) were treated at an early stage of the disease, while 25 cattle (39.7%) were treated at an advanced stage of the disease. The rectal body temperature of 90.5% of buparvaquone-treated cattle dropped to normal values (37.5-39.5 degrees C) by day 7 of treatment, and by day 15 of treatment 96.8% of treated cattle showed normal values. Pulmonary signs were observed in 8/68 (11.8%) of total ECF diagnosed cattle and were successfully treated, albeit with parvaquone plus frusemide (Fruvexon); were not included in final evaluation of the efficacy of BUTA-kel. The present evaluation trials record a recovery rate of 95.2%. Buparvaquone (BUTA-kel KELA Laboratoria, N.V. Belgium), therefore, records another efficacious and valuable alternative treatment against East Coast fever in Tanzania.  相似文献   

4.
Ten naphthoquinones, including parvaquone (993C) (Clexon; Wellcome) and menoctone, were tested for activity in cattle artificially infected with Theileria parva, the causative organism of East Coast fever (ECF). Parvaquone cured all 14 cattle treated with a single dose of 20 mg/kg intramuscularly and all five treated twice with 10 mg/kg intramuscularly. Menoctone cured seven of 10 cattle treated with a single dose of 5 mg/kg intramuscularly. Of 25 untreated control cattle, 22 died of ECF. None of the remaining eight naphthoquinones was as active as parvaquone. Three esters of active naphthoquinones, designed as 'prodrugs' of their parent compounds, showed little or no activity in infected cattle despite being highly active in vitro against T parva. These results were instrumental in the selection of parvaquone for development as the first specifically active remedy for ECF.  相似文献   

5.
A total of 90 animals was immunized against East Coast fever (ECF) using Theileria parva (Marikebuni) stock on three large-scale farms in Kiminini Division, Trans-Nzoia District, North Rift, Kenya. Another 90 cattle served as non-immunized controls. Following immunization the number of cattle with significant indirect fluorescent antibody (IFA) titres increased from 43.9% to 84.4% and 6.7% of the cattle developed clinical ECF reactions. Two months after immunization, the immunized and non-immunized cattle were divided into two groups one of which was dipped every 3 weeks and the other dipped when total full body tick counts reached 100. All the animals were monitored for 51 weeks for incidences of ECF and other tick-borne diseases. Twenty-four cases of ECF were diagnosed among the non-immunized cattle compared to four cases among the immunized cattle; a difference that was significant (P > 0.05). There was no significant difference in the incidences of babesiosis and anaplasmosis between the immunized and non-immunized cattle.  相似文献   

6.
East Coast fever (ECF) causes considerable mortality and production losses in the Tanzania smallholder dairy sector and limits the introduction of improved dairy breeds in areas where the disease is present. The infection and treatment method (ITM) was adopted by smallholder dairy farms for ECF immunisation in Hanang and Handeni districts of Tanzania. This study recorded incidence rates for ECF and other tick-borne diseases (TBDs) for ECF-immunised and non-immunised cattle between 1997 and 2000. Approximately 80% of smallholder households from both sites (n?=?167) participated in this longitudinal study, with immunisations carried out at the request of the livestock owners. Efficacy of ITM for preventing ECF cases in these crossbred dairy cattle was estimated at 97.6%, while that for preventing ECF deaths was 97.9%. One percent of the cattle developed clinical ECF as a result of immunisation. Since ECF immunisation permits a reduction in acaricide use, an increase in other TBDs is a potential concern. Sixty-three percent of farmers continued to use the same acaricide after immunisation, with 80% of these reducing the frequency of applications. Overall, 78% of farmers increased the acaricide application interval after immunisation beyond that recommended by the manufacturer, resulting in annual savings in the region of USD 4.77 per animal. No statistical difference was observed between the immunised and non-immunised animals in the incidence of non-ECF TBDs. However, immunised animals that succumbed to these diseases showed fewer case fatalities. ITM would therefore appear to be a suitable method for ECF control in Tanzania's smallholder dairy sector.  相似文献   

7.
A retrospective cross-sectional study of mortality was conducted on smallholder dairy farms in 2 separate regions (Iringa and Tanga) of Tanzania during the period of January to April 1999. A total of 1789 cattle from 400 randomly sampled smallholder dairy farms (200 each from Iringa and Tanga regions) were included in the study. These animals contributed a total risk period of 690.4 and 653.95 years for Tanga and Iringa, respectively. The overall mortality rates were estimated to be 8.5 and 14.2 per 100 cattle years risk for Tanga and Iringa regions, respectively; 57.7% of the reported deaths were of young stock less than 12 months old; 45% of reported young stock deaths (< or = 12 months old) were due to tickborne diseases, mainly East Coast Fever (ECF) and anaplasmosis. Disease events including ECF were reported to occur in all months of the year. Survival analysis using Cox proportional hazard models indicated that, in both regions, death rate and risk was higher in young stock less than 12 months than in older animals (relative risk RR = 4.92, P < 0.001 for Iringa; RR = 5.03 P = 0.005 for Tanga). In the Tanga region reported mortality rates were significantly higher for male animals (RR = 3.66, P = 0.001) and F2 compared with F1 animals (RR = 3.04, P = 0.003). In the Iringa region, reported mortality rates were lower for cattle on farms where the owner had attended a dairy development project training course (RR = 0.47, P = 0.012). Farms located in Iringa urban district and Pangani were associated with higher risk (mortality risk 21% for Iringa urban and 34% for Pangani). Our findings suggest that timely health and management interventions on these factors are necessary to alleviate losses from disease and emphasise that understanding variation in mortality risk within a population can enhance early response to potential outbreaks, reducing losses.  相似文献   

8.
Two groups of five cattle were immunised with a field isolate of Theileria parva as stabilate and simultaneously treated with long acting oxytetracycline or parvaquone in early clinical disease. The oxytetracycline group suffered a marked fall in leucocyte count and one animal died during immunisation. The parvaquone group suffered a less severe fall in leucocyte count and all survived. The surviving immunised cattle were immune to homologous challenge but susceptible to subsequent challenge with T p lawrencei.  相似文献   

9.
Parvaquone (BW993C), 2-cyclohexyl-3-hydroxy-1,4-naphthoquinone, and buparvaquone (BW720C) 2-(trans-4-t-butylcyclohexyl-methyl)-3-hydroxy-1,4-naphthoquinone, were evaluated to determine their therapeutic efficacy in the treatment of theileriosis caused by Theileria annulata infection in cattle in Iran. One hundred and fifty-nine pure and crossbred Bos taurus cattle, experimentally or naturally infected with T annulata, were treated. Parvaquone was injected into 86 animals with up to three doses of 20 mg kg-1 or 10 mg kg-1 at intervals of 48 hours between doses. Buparvaquone was injected into 73 animals. Up to three doses of 2.5 mg kg-1 were injected with an interval of 48 hours between doses. The recovery rate of animals treated with parvaquone was 60.7 per cent and with buparvaquone it was 88.7 per cent. No significant side effects of relapse of disease were observed following the use of either compound. It is concluded that buparvaquone at a dose of 2.5 mg kg-1 has a satisfactory therapeutic index and is a more effective treatment of T annulata infection than parvaquone. The prophylactic use of schizont tissue culture vaccine and chemotherapy with buparvaquone could be the most promising means of controlling theileriosis in Iran.  相似文献   

10.
A series of hydroxynaphthoquinones, all derivatives of the antitheilerial hydroxynaphthoquinone parvaquone (993C, Clexon; Wellcome) was tested for antitheilerial activity against Theileria parva (Muguga) in vitro. BW720C (buparvaquone) was 20 times more active than parvaquone. When tested in vivo BW720C cured all 13 cattle infected with T parva and all six infected with T annulata treated at a dose rate of 2.5 mg (kg bodyweight)-1 while parvaquone at 20 mg kg-1 cured nine of 10 cattle. All 16 untreated control cattle died of theileriosis.  相似文献   

11.
Five experiments were carried out to determine the efficacy of immunization against theileriosis in an endemic area of Kenya using artificial infection with a mixture of stabilates of Theileria parva stock or natural infection and treatment with parvaquone or several formulations of oxytetracyclines. For the first four experiments, introduced, susceptible Sahiwal/Friesian crosses were used and in the fifth, calves of Boran/Maasai zebu crosses born on the site. Cattle were infected either artificially with sporozoite stabilates of local isolates of T. parva parva derived from cattle and T. parva lawrencei derived from African buffalo or exposed to natural tick challenge on the ranch mostly derived from buffalo. The cattle were then given various treatment regimens using either parvaquone or long- and short-acting formulations of oxytetracycline. Treatment of natural infections, although it can be effective, was not considered a practical method on a large scale because of the need for intensive monitoring in the case of parvaquone treatment and the possibility of cattle not becoming infected in the case of prolonged application of long-acting formulations of oxytetracycline. Both methods were relatively expensive. Artificial infection treatment proved more practical and methods were developed where the monitoring of cattle was not required during the immunization procedure. Out of a total of 16 drug regimens investigated, one (consisting of two treatments of a short-acting formulation of oxytetracycline at 10 mg kg-1 body weight on Days 0 and 3 or 4 after infection) was found to be the most efficacious and the cheapest, and has now been used on a routine basis. This method can be used successfully on calves greater than 1 month of age.  相似文献   

12.
Summary Parvaquone was tested in cattle infected withTheileria annulata when they were presented at clinics in the vicinity of Baghdad. Out of over 200 cases presented with suspected theileriosis between July 1984 and July 1985, the drug was used in 45 cases where theileriosis was confirmed by microscopic examination of blood and lymph node biopsy smears. Twenty seven of the cases were considered mild and 18 cases severe. Weights of the cattle were estimated and parvaquone was administered by intramuscular injection at a nominal dose of 20 mg/kg. A single treatment with parvaquone was used in 25 cases and 20 cases were treated twice but there was no correlation between severity of disease and the number of treatments given. Twelve cases (27%) also received antibacterial therapy. All cases were in exotic cattle or cattle born from exotic (imported) cattle and 64% of the cases were in cattle under six months of age. Temperatures dropped immediately after treatment and the majority were normal (below 39.5°C) by two to three days after the first treatment. Of the 45 cases treated 43 recovered. This compares very favourably with a previously reported mortality of 66% in untreated imported cattle in Iraq.
Eficacia Del Parvaquone En El Tratamiento De La Theilerosis Natural En Ganado En Iraq
Resumen Se trató ganado infectado conTheileria annulata en forma natural con parvaquone, en clínicas veterinarias localizadas en la vecindad de Baghdad. De 200 casos admitidos con sospecha de theileriosis, entre julio 1984 y julio 1985, la droga se usó en 45 casos confirmados mediante el examen microscópico de frotis de sangre y biopsias de ganglios linfáticos. Veintisiete de los casos se consideraron moderados y 18 casos severos. Se estimaron los pesos de los animales enfermos, suministrandoles parvaquone vía intramuscular en dosis nominales de 20 mg/kg (rango 16–35 mg/kg). Se utilizó un solo tratamiento con parvaquone en 25 casos clínicos, mediante la aplicación de una sola inyección y se aplicaron dos inyecciones en 20 casos (doble tratamiento), sin que se encontrara correlación alguna entre la severidad de la enfermedad, recuperación y número de tratamientos. Doce casos (27%) recibieron también algún tratamiento antibacteriano. Todos los casos de theileriosis se presentaron en ganado exótico o nacido de ganado exótico (importado) y 64% de los casos ocurrieron en ganado bajo los seis meses de edad. La temperatura bajó inmediatamente después del tratamiento, normalizándose dos o tres días después de tratamiento (bajo 39.5°C). De los 45 casos tratados 43 se recuperaron. Se informa una mortalidad previa de 60% en ganado importado no tratado contra theileriosis en Iraq.
Efficacite De La Parvaquone Pour Le Traitement De La Theileriose Naturelle Des Bovins En Irak
Résumé La parvaquone a été essayée pour le traitement de bovins infectés parTheileria annulata lorsqu'ils étaient présentés aux cliniques des environs de Bagdad. Sur plus de 200 cas présentés pour suspicion de theilériose entre juillet 1984 et juillet 1985, le médicament a été utilisé dans 45 cas où la theilériose était confirmée par l'examen microscopique du sang et de biopsies de ganglions lymphatiques, 27 cas étaient considérés comme des atteintes modérées et 18 comme des cas graves. Les poids des animaux étaient estimés à l'oeil et la parvaquone administrée par voie intra-musculaire à la dose normale de 20 mg/kg (soit 16 à 35 mg/kg). Un traitement unique à la parvaquone a été pratiqué dans 25 cas et il a du être renouvelé dans 20 cas mais il n'y avait pas corrélation entre la gravité des symptômes et le nombre de traitements requis. Dans 12 cas (27%) une thérapie antibactérienne a également été mise en oeuvre. Tous les malades étaient des animaux importés ou issus d'animaux importés et dans 64% des cas les animaux étaient âgés de moins de 6 mois. Les températures ont chuté immédiatement après le traitement et, pour la plupart, étaient normales (moins de 39°5) deux à trois jours après le traitement—sur 45 animaux traités, 43 ont guéri. Ces résultats apparaissent très favorables par rapport à la mortalité de 66% rapportée antérieurement et affectant les bovins non traités en Irak.
  相似文献   

13.
Two experiments were carried out in which parvaquone was used to treat experimentally-induced acute clinical East Coast fever infections. In the first experiment, infections with Theileria parva parva (Kiambu 5) were induced by applying infected Rhipicephalus appendiculatus ticks or by inoculation of triturated infected-tick stabilate. The character of the disease was similar with both methods of infection and following a single treatment with parvaquone at 20 mg kg-1, 5 of 7 cattle in each group recovered. All untreated control cattle died. In the second experiment, 5 stabilate isolates from different locations within East Africa, and representative of the challenge likely to be met in the field, were used. Treatment was administered in 2 X 10 mg kg-1 doses 48 h apart. The isolates used were T. p. parva (Mbita), T. p. parva (Pugu), T. p. parva (Entebbe), T. p. lawrencei (Mara) and T. p. lawrencei/(Manyara); following treatment 3/7, 6/6, 6/7, 5/7 and 6/7 animals recovered, respectively. All untreated control cattle died. There was evidence of a difference in susceptibility of isolates to treatment, and some animals showed prolonged disease episodes. The nature of the response to treatment and the problems in treating a lympho-destructive disease are discussed.  相似文献   

14.
A prospective observational study was conducted among smallholder dairy farmers in Murang'a District, Kenya, to estimate the incidence of Theileria parva infections, as well as calf morbidity and mortality caused by the infection. The study was conducted between March 1995 and August 1996, in five cohorts of female calves from birth to six months of age from different agro-ecological zones (AEZs) and grazing-system strata shown previously to have varying prevalences of T. parva infection. A total of 188 smallholder dairy farms with 225 female calves were selected purposively by five AEZ-grazing strata. All recruited calves were visited within the first two weeks of life and thereafter at biweekly intervals up to the age of six months. The mean number of cattle in these smallholder farms was 2.6. Both exotic and indigenous breeds of cattle and their crosses were present, with the former predominating. The incidence (27-54%) of sero-conversion to T. parva in an ELISA test was significantly different (p < 0.05) across the five AEZ-grazing strata and increased with lower elevation and unrestricted grazing. Calf morbidity and mortality were also variable across the AEZ-grazing strata. East Coast fever (ECF) was the highest-incidence cause calf morbidity and mortality (relative to other diseases). There are great differences in the epidemiology of ECF within a small area and this implies that there is need to carefully consider different ECF control strategies in different AEZ-grazing strata.  相似文献   

15.
A controlled trial was conducted to evaluate the current efficacy of albendazole (ABZ), rafoxanide (RFX), triclabendazole (TRC) or clorsulon (CLS) against Fasciola hepatica in naturally infected cattle. This trial was conducted in Turkey during the spring, the time of year when liver fluke infection is endemic. Fifty crossbred cattle were selected for inclusion in the trial based on finding eggs of F. hepatica in the feces. The cattle were weighed and randomly allotted into five groups of 10 cattle and treatments were as follows: Group 1 served as non-treated control (CONT), Group 2 was treated orally with ABZ at 12 mg/kg, Group 3 was treated orally with RFX at 10 mg/kg, Group 4 received TRC orally at 12 mg/kg and Group 5 received CLS administered subcutaneously (s.c.) at 2 mg/kg. On day 0 (inclusion day), individual fecal samples were collected on days 0 (inclusion day), 7, 14, 28 and 56, after treatment. The drug efficacy was assessed as a percentage of the egg or fluke reduction and body weight gain relative to the untreated control. The results in the study showed a mean reduction of egg counts by 66.7%, 68.2%, 78% and 84.2% in Groups 2-5, respectively. In conclusion, our results indicate that CLS is a highly effective compound for the treatment of F. hepatica in cattle under these field conditions.  相似文献   

16.
Epidemiologic indicators associated with within-farm infection of Johne's disease in dairy farms in Japan were determined through a nationwide investigation of infected farms. We assumed that subsequent detection of the disease within one year after the first detection could represent the occurrence of within-farm spread occurring before the first detection. Of 594 infected farms, 158 farms (27%) had at least one additional detection. Logistic regression analysis using epidemiologic information obtained from infected farms at the time of the first detection revealed three epidemiologic indicators associated with subsequent detection. Farms at which the first cases included cattle with clinical signs were 3.8 (95% confidence interval: 2.2, 6.8) times more likely to have additional detections than those with cattle without clinical signs. Similarly, farms where two or more cattle were detected at the time of first detection and where cattle were held in a loose housing system were 2.8 (95% CI: 1.8, 4.5) and 2.0 (95% CI: 1.1, 3.6) times more likely to have additional detections than those where only one animal was detected and a tied-up housing system was used, respectively. These epidemiologic indicators are likely important determinants in the selection of farms requiring more intensive on-farm control measures.  相似文献   

17.
本试验选取新疆垦区七个试验牛场,临床调查和试剂诊断,检测奶牛712头,采集奶牛乳房炎阳性乳样314份。其中,奶牛隐性乳房炎阳性检出率平均为36.3%,临床性奶牛乳房炎为16.7%;采集阳性奶样经试验分离鉴定,革兰氏阳性菌仍是引起奶牛乳房炎的主要致病菌,但金色葡萄球菌已基本取代链球菌成为主要的致病菌,其检出率为78.98%。另外,常见环境性致病菌如沙门氏菌、大肠杆菌已明显减少,检出率仅为21.1%和9.24%。相反,绿脓杆菌和蜡样芽孢杆菌的检出率明显增加,其检出率为5.41%和11.15%,而且绿脓杆菌和隐球菌已经成为引起临床性乳房炎爆发的两种新的病原,其中隐球菌已经成为造成顽固性乳房炎的又一种新型病原。  相似文献   

18.
Two experiments were conducted to evaluate the effects of feeding different levels of wet corn gluten feed (WCGF) and dietary roughage on performance, carcass characteristics, and feeding behavior of feedlot cattle fed diets based on steam-flaked corn (SFC). In Exp. 1, crossbred steers (n = 200; BW = 314 kg) were fed 4 dietary treatments (DM basis): a standard SFC-based diet containing 9% roughage (CON) and 3 SFC-based diets containing 40% WCGF, with either 9, 4.5, or 0% roughage. A linear (P = 0.04) increase in final BW and DMI (P < 0.01) was observed in diets containing WCGF as dietary roughage increased. Steers fed WCGF and higher levels of roughage had greater (P = 0.01) ADG than steers fed lower levels of roughage. Steers fed the CON diet had lower (P = 0.04) daily DMI and greater (P = 0.03) G:F than those fed WCGF. Most carcass characteristics of steers fed CON did not differ (P > 0.10) from those of steers fed WCGF. Based on feed disappearance and visual scan data, consumption rate did not differ (P > 0.10) among treatments; however, feeding intensity (animals present at the bunk after feeding) was greater for steers fed CON (P < 0.01) than for steers fed WCGF. In Exp. 2, yearling crossbred steers (n = 1,983; BW = 339 kg) were fed 4 dietary treatments (DM basis): a standard SFC-based control diet that contained 9% roughage (CON) and 3 SFC-based diets containing either 20% WCGF and 9% roughage or 40% WCGF with 9 or 4.5% roughage. Steers fed the CON diet tended to have lower final BW (P = 0.14), ADG (P = 0.01), and DMI (P < 0.01) than steers fed diets containing WCGF. Steers fed the 20% WCGF diet had greater (P = 0.08) G:F than steers fed the 40% WCGF diets. With 40% WCGF, increasing roughage from 4.5 to 9% decreased (P < 0.01) G:F and increased (P = 0.06) DMI. Gain efficiency was improved (P < 0.01) for steers fed CON vs. those fed diets containing WCGF, whereas HCW (P = 0.02) and dressing percentage (P < 0.01) were greater for steers fed WCGF. Percentage of cattle grading USDA Choice was greater (P = 0.02) for cattle fed WCGF. Results suggest that replacing SFC with up to 40% WCGF increased ADG and decreased G:F when 4.5 to 9.0% roughage was supplied. More CON steers were present at the feed bunk during the first hour after feeding than WCGF steers, suggesting that including WCGF at 40% of the diet affected feeding behavior.  相似文献   

19.
为比较安格斯牛和昭通牛的杂交效果,进行了安昭牛F1代和昭通牛的短期育肥研究.结果表明:安昭牛和昭通牛平均日增重、屠宰率、净肉率、眼肌面积分别为1.179 kg、53.72%、45.11%、86.35 cm2和0.849 kg、48.83%、39.84%、55.65 cm2,安昭牛均极显著高于昭通牛(P＜0.01),胴体脂肪覆盖率分别为82.98%和69.98%,安昭牛优于昭通牛(P＜0.05);而安昭牛肉蛋白质含量20.6%,极显著低于昭通牛的23.65%(P＜0.01),脂肪含量26.3%显著高于昭通牛的7.85%(P＜0.05),总氨基酸含量、必需氨基酸含量分别为86.43 mg/100mg、83.06 mg/100mg和38.47 mg/100mg、36.38 mg/100mg,安昭牛亦极显著(P＜0.01)和显著(P＜0.05)高于昭通牛.  相似文献   

20.
A field trial was carried out with Nobi-Vac AR vaccine in 11 swine breeding herds. One herd suffered from severe B. bronchiseptica (BB+) rhinitis in piglets, while no clinical Atrophic Rhinitis (AR) was observed. Ten herds were described as AR problem herds, because clinical AR was observed for at least 1 year in spite of the fact that medication of sows and piglets was carried out and adequate housing and management systems were available in most herds. BB+ was isolated in 9 of these 10 farms and the AR pathogenic P. multocida (PM+) in all these farms. The trial started when piglets were born of sows which had been vaccinated 3 times. All piglets between 7 and 10 weeks old were examined clinically for AR. Nasal swabs from 20 pigs on each farm were screened bacteriologically for BB+ and PM+ every other month. A severe reoccurrence of AR was found in 2 of the 10 AR problem farms. In these 2 herds the 'all in-all out' system was not applied in farrowing and weaning houses. In the 8 other AR problem herds the percentage of pigs with AR decreased significantly below the average level of 1% per year. The percentage of pigs infected with BB+ and PM+ also decreased significantly. PM+ was significantly related to the percentage of clinical AR piglets. Seasonal effects contributed to a minor extent to the percentage of AR piglets. After 2.5 years of this trial PM+ could not be isolated during the last 12 months in six of the remaining AR problems herds. The conclusion is that Nobi-Vac AR vaccination of the sow gave protection against clinical AR in piglets on those farms (80%) which provided adequate housing and management systems.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号